Pharma warehouse keystone of new Grifols Dublin facility
Grifols is the world’s third-largest plasma product manufacturer and opened the Bioscience Division of its new worldwide operations facility in Ireland.
The site will house operating activities such as warehousing of plasma, intermediate paste and finished product; labeling, packaging, final conditioning; administrative procedures and final validations release activities related to plasma supply, among others.
Total investment in the project has reached 100 million dollars and the facility is expected to become fully operational early next year.
The 22,000 sq m site will facilitate the global distribution of plasma-derived products supporting operations in over 67 countries by ‘maximising the flexibility and security of supplies’.
It will be the central warehouse for all plasma coming from the United States, as it has the capacity to store up to 1,150 pallets of plasma at -30 degrees centigrade, and is equipped with quality control laboratories.
Dublin will be the central warehouse for intermediate and finished products, with capacity to store up to 3,000 pallets of intermediate and finished products at a temperature of +5 degrees centigrade.
It will centralise the tasks of labeling, packing, final conditioning, and distribution of finished plasma product to all Grifols’ commercial subsidiaries and global distributors, other than Spain and the United States, facilitating a fast flow of goods. It has 4 labeling and packing lines. The company expects to process about 10 million product vials in 2016. This amount will double up in the long term.
